Health

Results: 5389-5400 of 6059

MULTI-MILLION POUND BOOST FOR RESEARCH PROJECTS AIMED AT DEVELOPING NEW TESTS, TREATMENTS AND DEVICES FOR NEURODEGENERATIVE DISEASES

PR Newswire associated0

Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

PR Newswire associated0

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

PR Newswire associated0

LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

PR Newswire associated0

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

PR Newswire associated0

Millar to Acquire Sentron; Redefining MEMS Pressure Sensor Industry

Business Wire logo

Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments

PR Newswire associated0

Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

Business Wire logo

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1

PR Newswire associated0

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591